Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: Insights into the influence of diet, gender and aging

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Meyrelles, Silvana S ^a   Peotta, Veronica A ^b   Pereira, Thiago M C ^c   Vasquez, Elisardo C ^a,d  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

^c Federal Institute of Education   (Brazil)

^d Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

apoE; atherosclerosis; endothelial dysfunction; gender; hypercholesterolemia; oxidative stress

Indexed keywords

APOLIPOPROTEIN E; CYCLIC AMP; CYCLIC GMP; ENDOTHELIN; LIPID; LIPOPROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

AGING; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; DIET; ENDOTHELIAL DYSFUNCTION; GENDER; LIPID BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN DEFICIENCY; RESISTANCE BLOOD VESSEL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; ANIMAL; BLOOD; DISEASE MODEL; ENDOTHELIUM; ENZYMOLOGY; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT;

MURINAE; MUS;

AGING; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET; DISEASE MODELS, ANIMAL; ENDOTHELIUM; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; SEX CHARACTERISTICS;

EID: 81055138804     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-211     Document Type: Review

References (125)

1. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Breslow JL, Proc Natl Acad Sci USA 1993 90 18 8314 8 10.1073/pnas.90.18.8314 8378301 (Pubitemid 23277658)
2. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N, Proc Natl Acad Sci USA 1992 89 10 4471 5 10.1073/pnas.89.10.4471 1584779
3. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL, Cell 1992 71 2 343 53 10.1016/0092-8674(92)90362-G 1423598
4. Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression. Deckert V, Lizard G, Duverger N, Athias A, Palleau V, Emmanuel F, Moisant M, Gambert P, Lallemant C, Lagrost L, Circulation 1999 100 11 1230 5 10484545 (Pubitemid 29426600)
5. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL, Circulation 2001 104 4 448 54 10.1161/hc2901.091399 11468208 (Pubitemid 32678276)
6. Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I (Milano)-phospholipid complex. Kaul S, Coin B, Hedayiti A, Yano J, Cercek B, Chyu KY, Shah PK, J Am Coll Cardiol 2004 44 6 1311 9 10.1016/j.jacc.2004.06.028 15364338 (Pubitemid 39208891)
7. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Wassmann S, Czech T, van Eickels M, Fleming I, Böhm M, Nickenig G, Circulation 2004 110 19 3062 7 10.1161/01.CIR.0000137970.47771.AF 15277329 (Pubitemid 39491999)
8. MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Ohashi M, Runge MS, Faraci FM, Heistad DD, Arterioscler Thromb Vasc Biol 2006 26 10 2331 6 10.1161/01.ATV.0000238347.77590.c9 16873728 (Pubitemid 44465730)
9. Mouse models of experimental atherosclerosis. Jawie J, Nastaek P, Korbut R, J Physiol Pharmacol 2004 55 3 503 17 15381823 (Pubitemid 39318844)
10. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Meir KS, Leitersdorf E, Arterioscler Thromb Vasc Biol 2004 24 6 1006 14 10.1161/01.ATV.0000128849.12617.f4 15087308 (Pubitemid 38737824)
11. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, Science 1992 258 5081 468 71 10.1126/science.1411543 1411543
12. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM, Arterioscler Thromb Vasc Biol 1997 17 11 2333 40 10.1161/01.ATV.17.11.2333 9409199 (Pubitemid 28015965)
13. Quantitative assessment of atherosclerotic lesions in mice. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA, Atherosclerosis 1987 68 3 231 40 10.1016/0021-9150(87)90202-4 3426656 (Pubitemid 17159775)
14. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Paigen B, Holmes PA, Mitchell D, Albee D, Atherosclerosis 1987 64 2-3 215 21 10.1016/0021-9150(87)90249-8 3606719 (Pubitemid 17047164)
15. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Mahley RW, Science 1988 240 4852 622 30 10.1126/science.3283935 3283935
16. Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia. Stapleton PA, Goodwill AG, James ME, Frisbee JC, Am J Physiol Regul Integr Comp Physiol 2007 293 3 1110 9 10.1152/ajpregu.00410.2007 17626122 (Pubitemid 47358931)
17. Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Lee MY, Li H, Xiao Y, Zhou Z, Xu A, Vanhoutte PM, Br J Pharmacol 2011 162 7 1564 76 10.1111/j.1476-5381.2010.01158.x 21175571
18. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. Zhang SH, Reddick RL, Burkey B, Maeda N, J Clin Invest 1994 94 3 937 45 10.1172/JCI117460 8083379 (Pubitemid 24286433)
19. Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Niebauer J, Maxwell AJ, Lin PS, Tsao PS, Kosek J, Bernstein D, Cooke JP, Am J Physiol 1999 276 4 Pt 2 1346 54 10199861
20. (A)receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. d'Uscio LV, Barton M, Shaw S, Lüscher TF, Cardiovasc Res 2002 53 2 487 95 10.1016/S0008-6363(01)00469-2 11827700 (Pubitemid 34117700)
21. Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein E-deficient mice with different genetic backgrounds. Surra JC, Guillén N, Arbonés-Mainar JM, Barranquero C, Navarro MA, Arnal C, Orman I, Segovia JC, Osada J, J Atheroscler Thromb 2010 17 7 712 21 10.5551/jat.3541 20460831
22. Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice. Jiang F, Gibson AP, Dusting GJ, Eur J Pharmacol 2001 424 2 141 9 10.1016/S0014- 2999(01)01140-2 11476760 (Pubitemid 32718618)
23. Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Gervais M, Pons S, Nicoletti A, Cosson C, Giudicelli JF, Richer C, Arterioscler Thromb Vasc Biol 2003 23 2 183 9 10.1161/01.ATV.0000051404.84665.49 12588757 (Pubitemid 36231926)
24. 2and decreased prostacyclin production. Smith DD, Tan X, Tawfik O, Milne G, Stechschulte DJ, Dileepan KN, J Physiol Pharmacol 2010 61 3 309 16 20610861
25. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R, Arterioscler Thromb 1994 14 1 133 40 10.1161/01.ATV.14.1.133 8274468
26. 0) mice. Coleman R, Hayek T, Keidar S, Aviram M, Acta Histochem 2006 108 6 415 24 10.1016/j.acthis.2006.07.002 17007910 (Pubitemid 44708294)
27. In vivo angiographic detection of vascular lesions in apolipoprotein E-knockout mice using a synchrotron radiation microangiography system. Yamashita T, Kawashima S, Ozaki M, Namiki M, Shinohara M, Inoue N, Hirata K, Umetani K, Yokoyama M, Circ J 2002 66 11 1057 9 10.1253/circj.66.1057 12419940 (Pubitemid 35416345)
28. Gender differences in cardiovascular disease: hormonal and biochemical influences. Pérez-Lápez FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS, Reprod Sci 2010 17 6 511 31 10.1177/1933719110367829 20460551
29. Gender as a regulator of atherosclerosis in murine models. Thomas CM, Smart EJ, Curr Drug Targets 2007 8 1172 80 10.2174/138945007782403874 18045095 (Pubitemid 350238918)
30. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. Tangirala RK, Rubin EM, Palinski W, J Lipid Res 1995 36 11 2320 8 8656070
31. 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Elhage R, Arnal JF, Pieraggi MT, Duverger N, Fiévet C, Faye JC, Bayard F, Arterioscler Thromb Vasc Biol 1997 17 11 2679 84 10.1161/01.ATV.17.11.2679 9409242 (Pubitemid 28016008)
32. -/-) mice. Chiba T, Ikeda M, Umegaki K, Tomita T, Atherosclerosis 2011
33. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ, Proc Natl Acad Sci USA 1996 93 19 10022 7 10.1073/pnas.93.19.10022 8816744 (Pubitemid 26314567)
34. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. Grey AB, Stapleton JP, Evans MC, Reid IR, J Clin Endocrinol Metab 1995 80 11 3191 5 10.1210/jc.80.11.3191 7593425
35. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. Reckless J, Metcalfe JC, Grainger DJ, Circulation 1997 95 6 1542 8 9118523 (Pubitemid 27142813)
36. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK, Atherosclerosis 1999 145 2 301 8 10.1016/S0021-9150(99)00081-7 10488957 (Pubitemid 29359138)
37. Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Freudenberger T, Oppermann M, Heim HK, Mayer P, Kojda G, Schrör K, Fischer JW, Basic Res Cardiol 2010 105 4 479 86 10.1007/s00395-010-0091-6 20177692
38. Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds. Maeda N, Johnson L, Kim S, Hagaman J, Friedman M, Reddick R, Atherosclerosis 2007 195 1 75 82 10.1016/j.atherosclerosis.2006.12.006 17275002 (Pubitemid 47561948)
39. Role of endothelial dysfunction in atherosclerosis. Davignon J, Ganz P, Circulation 2004 109 23 Suppl 1 II27 32 15198963
40. Endothelial dysfunction in atherosclerosis. Harrison DG, Basic Res Cardiol 1994 89 Suppl1 87 102 7945179 (Pubitemid 24314600)
41. Endothelial function: a critical determinant in atherosclerosis? Landmesser U, Hornig B, Drexler H, Circulation 2004 109 21 Suppl 1 I27 33 15173060
42. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Katusic ZS, Am J Physiol Heart Circ Physiol 2001 281 3 981 6 11514262
43. NADPH oxidase and endothelial cell function. Ray R, Shah AM, Clin Sci (Lond) 2005 109 3 217 26 10.1042/CS20050067 (Pubitemid 41337126)
44. NADPH oxidases: Functions and pathologies in the vasculature. Lassègue B, Griendling KK, Arterioscler Thromb Vasc Biol 2010 30 4 653 61 10.1161/ATVBAHA.108.181610 19910640
45. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Sirker A, Zhang M, Shah AM, Basic Res Cardiol 2011 106 5 735 47 10.1007/s00395-011-0190-z 21598086
46. Superoxide Dismutases: role in redox signaling, vascular function, and diseases. Fukai T, Ushio-Fukai M, Antioxid Redox Signal 2011 15 6 1583 606 10.1089/ars.2011.3999 21473702
47. EDHF: bringing the concepts together. Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH, Trends Pharmacol Sci 2001 23 8 374 80
48. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Shimokawa H, Matoba T, Pharmacol Res 2004 49 6 543 9 10.1016/j.phrs.2003.10.016 15026032 (Pubitemid 38338664)
49. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Ardanaz N, Pagano PJ, Exp Biol Med (Maywood) 2006 231 3 237 51 (Pubitemid 43334308)
50. Reactive oxygen species and vascular biology: implications in human hypertension. Touyz RM, Briones AM, Hypertens Res 2011 34 1 5 14 10.1038/hr.2010.201 20981034
51. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta. Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ, Br J Pharmacol 1993 110 1 151 8 7693274 (Pubitemid 23257772)
52. Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor. Capettini LS, Cortes SF, Gomes MA, Silva GA, Pesquero JL, Lopes MJ, Teixeira MM, Lemos VS, Am J Physiol Heart Circ Physiol 2008 295 6 2503 11 10.1152/ajpheart.00731.2008 18952716
53. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Thengchaisri N, Kuo L, Am J Physiol Heart Circ Physiol 2003 285 6 2255 63 14613908
54. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A, J Clin Invest 2000 106 12 1521 30 10.1172/JCI10506 11120759 (Pubitemid 32040953)
55. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cai H, Cardiovasc Res 2005 68 1 26 36 10.1016/j.cardiores.2005.06.021 16009356 (Pubitemid 41253553)
56. EDHF: an update. Félétou M, Vanhoutte PM, Clin Sci (Lond) 2009 117 4 139 55 10.1042/CS20090096
57. Assessment and treatment of endothelial dysfunction in humans. Anderson TJ, J Am Coll Cardiol 1999 34 3 631 8 10.1016/S0735-1097(99)00259-4 10483941 (Pubitemid 29436165)
58. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Cai H, Harrison DG, Circ Res 2000 87 10 840 4 11073878
59. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Félétou M, Vanhoutte PM, Am J Physiol Heart Circ Physiol 2006 291 3 985 1002 10.1152/ajpheart.00292.2006 16632549 (Pubitemid 44343640)
60. Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation. Simonsen U, Rodriguez-Rodriguez R, Dalsgaard T, Buus NH, Stankevicius E, Pharmacol Rep 2009 61 1 105 15 19307698
61. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Ross R, Am J Pathol 1993 143 4 987 1002 8214014 (Pubitemid 24070539)
62. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, Mallari C, Martin-McNulty B, da Cunha V, Freay A, Rubanyi GM, Kauser K, Am J Physiol Heart Circ Physiol 2000 278 2 428 34 10666072
63. Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Fransen P, Van Assche T, Guns PJ, Van Hove CE, De Keulenaer GW, Herman AG, Bult H, Pflugers Arch 2008 455 5 811 8 10.1007/s00424-007-0337-9 17899169 (Pubitemid 350265620)
64. Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice. Villeneuve N, Fortuno A, Sauvage M, Fournier N, Breugnot C, Jacquemin C, Petit C, Gosgnach W, Carpentier N, Vanhoutte P, Vilaine JP, J Vasc Res 2003 40 2 87 96 10.1159/000070705 12808344 (Pubitemid 36735218)
65. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. Yaghoubi M, Oliver-Krasinski J, Cayatte AJ, Cohen RA, J Cardiovasc Pharmacol 2000 36 6 751 7 10.1097/00005344-200012000-00010 11117375
66. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. Crauwels HM, Van Hove CE, Holvoet P, Herman AG, Bult H, Cardiovasc Res 2003 59 1 189 99 10.1016/S0008-6363(03)00353-5 12829190 (Pubitemid 36776385)
67. Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis. Guns PJ, Van Assche T, Verreth W, Fransen P, Mackness B, Mackness M, Holvoet P, Bult H, Br J Pharmacol 2008 153 3 508 16 10.1038/sj.bjp.0707585 18059326 (Pubitemid 351199014)
68. Areceptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Münter K, Lüscher TF, Proc Natl Acad Sci USA 1998 95 24 14367 72 10.1073/pnas.95.24.14367 9826706 (Pubitemid 28549373)
69. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS, Arterioscler Thromb Vasc Biol 2001 21 6 1017 22 10.1161/01.ATV.21.6.1017 11397713 (Pubitemid 34168662)
70. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabá C, Int J Mol Med 2002 9 6 659 64 12011985
71. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Benkö R, Pacher P, Vaslin A, Kollai M, Szabá C, Life Sci 2004 75 10 1255 61 10.1016/j.lfs.2004.04.007 15219813 (Pubitemid 38829350)
72. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice. Mujynya-Ludunge K, Viswambharan H, Driscoll R, Ming XF, von Segesser LK, Kappenberger L, Yang Z, Vassalli G, Basic Res Cardiol 2005 100 2 102 11 10.1007/s00395-004-0500-9 15578196 (Pubitemid 40372078)
73. New insights into the vascular mechanisms underlying the beneficial effect of swimming training on the endothelial vasodilator function in apolipoprotein E-deficient mice. Pellegrin M, Berthelot A, Houdayer C, Gaume V, Deckert V, Laurant P, Atherosclerosis 2007 190 1 35 42 10.1016/j. atherosclerosis.2006.02.001 16529753 (Pubitemid 44908319)
74. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U, Circulation 2008 117 18 2377 87 10.1161/CIRCULATIONAHA.107.746537 18443241 (Pubitemid 351653554)
75. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Vinh A, Widdop RE, Drummond GR, Gaspari TA, Cardiovasc Res 2008 77 1 178 87 18006471 (Pubitemid 351195149)
76. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE, Arterioscler Thromb Vasc Biol 2010 30 8 1606 13 10.1161/ATVBAHA.110. 204453 20448208
77. Haemodynamically significant plaque formation and regional endothelial dysfunction in cholesterol-fed ApoE-/- mice. Johansson ME, Hägg U, Wikström J, Wickman A, Bergström G, Gan LM, Clin Sci (Lond) 2005 108 6 531 8 10.1042/CS20040322 (Pubitemid 40827561)
78. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE, Am J Cardiol 1991 68 15 1425 30 10.1016/0002-9149(91)90274-O 1746422
79. Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide. Raman KG, Gandley RE, Rohland J, Zenati MS, Tzeng E, J Vasc Surg 2011 53 3 754 63 10.1016/j.jvs.2010.09.038 21163611
80. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. d'Uscio LV, Smith LA, Katusic ZS, Stroke 2001 32 11 2658 64 10.1161/hs1101.097393 11692031 (Pubitemid 33055321)
81. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Böhm F, Ahlborg G, Pernow J, Clin Sci (Lond) 2002 102 3 321 7 10.1042/CS20010217 (Pubitemid 34214395)
82. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher T, Rabelink T, J Clin Invest 1997 99 1 41 6 10.1172/JCI119131 9011574 (Pubitemid 27058292)
83. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG, Circulation 2001 103 9 1282 8 11238274 (Pubitemid 32221353)
84. -/-) mice. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS, J Clin Invest 2001 108 10 1513 22 11714743 (Pubitemid 33091989)
85. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Laufs U, Wassmann S, Czech T, Münzel T, Eisenhauer M, Böhm M, Nickenig G, Arterioscler Thromb Vasc Biol 2005 25 4 809 14 10.1161/01.ATV.0000158311.24443.af 15692095 (Pubitemid 40463874)
86. Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Matsumoto T, Miyamori K, Kobayashi T, Kamata K, Free Radic Biol Med 2006 41 8 1289 303 10.1016/j.freeradbiomed.2006.07.012 17015176 (Pubitemid 44466326)
87. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Jiang F, Guo Y, Salvemini D, Dusting GJ, Br J Pharmacol 2003 139 6 1127 34 10.1038/sj.bjp.0705354 12871831 (Pubitemid 36920675)
88. 1Areceptor. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA, Circulation 2004 110 25 3849 57 10.1161/01.CIR.0000150540.54220.C4 15596561 (Pubitemid 40023984)
89. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Arakawa K, Urata H, Hypertension 2000 36 4 638 41 11040250
90. Free radical production and angiotensin. Wolf G, Curr Hypertens Rep 2000 2 2 167 73 10.1007/s11906-000-0078-z 10981145
91. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Weiss D, Kools JJ, Taylor WR, Circulation 2001 103 3 448 54 11157699 (Pubitemid 32105987)
92. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Tham DM, Martin-McNulty B, Wang YX, Da Cunha V, Wilson DW, Athanassious CN, Powers AF, Sullivan ME, Rutledge JC, Am J Physiol Regul Integr Comp Physiol 2002 283 6 1442 9 12388474
93. -/- mice. Mazzolai L, Duchosal MA, Korber M, Bouzourene K, Aubert JF, Hao H, Vallet V, Brunner HR, Nussberger J, Gabbiani G, Hayoz D, Hypertension 2004 44 3 277 82 10.1161/01.HYP.0000140269. 55873.7b 15302839 (Pubitemid 39167222)
94. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T, Circulation 1999 99 15 2027 33 10209008 (Pubitemid 29183901)
95. Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Williams KJ, Scalia R, Mazany KD, Rodrigueza WV, Lefer AM, Arterioscler Thromb Vasc Biol 2000 20 4 1033 9 10.1161/01.ATV.20.4.1033 10764669 (Pubitemid 30207578)
96. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL, Circulation 2003 107 19 2480 6 10.1161/01.CIR.0000065601.83526.3E 12719275 (Pubitemid 36605232)
97. -/- mouse but prevented by atorvastatin. Maguire JJ, Wiley KE, Kuc RE, Stoneman VE, Bennett MR, Davenport AP, Exp Biol Med (Maywood) 2006 231 6 806 12 (Pubitemid 43845532)
98. Rapamycin modulates the eNOS vs. shear stress relationship. Cheng C, Tempel D, Oostlander A, Helderman F, Gijsen F, Wentzel J, van Haperen R, Haitsma DB, Serruys PW, van der Steen AF, de Crom R, Krams R, Cardiovasc Res 2008 78 1 123 9 10.1093/cvr/cvm103 18079107 (Pubitemid 351430952)
99. Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice. Gadioli AL, Nogueira BV, Arruda RM, Pereira RB, Meyrelles SS, Arruda JA, Vasquez EC, Braz J Med Biol Res 2009 42 12 1191 5 10.1590/S0100-879X2009005000036 19893993
100. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Zeiher AM, Drexler H, Wollschläger H, Just H, Circulation 1991 84 5 1984 92 1934373
101. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H, Arterioscler Thromb Vasc Biol 1999 19 11 2762 8 10.1161/01.ATV.19.11.2762 10559023 (Pubitemid 29536055)
102. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC, Hypertension 2005 46 4 932 6 10.1161/01.HYP.0000182154.61862.52 16087779
103. Oral P. gingivalis infection alters the vascular reactivity in healthy and spontaneously atherosclerotic mice. Pereira RB, Vasquez EC, Stefanon I, Meyrelles SS, Lipids Health Dis 2011 10 80 10.1186/1476-511X-10-80 21586133
104. Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo. Wölfle SE, de Wit C, J Vasc Res 2005 42 6 475 82 10.1159/000088101 16155363 (Pubitemid 41527602)
105. -/- mice involves NO but not prostacyclin-dependent mechanisms. Gödecke A, Ziegler M, Ding Z, Schrader J, Cardiovasc Res 2002 53 1 253 62 10.1016/S0008-6363(01)00432-1 11744035 (Pubitemid 34020787)
106. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Lamping KG, Nuno DW, Chappell DA, Faraci FM, Am J Physiol 1999 276 4 Pt 2 1023 9 10198381
107. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Xu X, Gao X, Potter BJ, Cao JM, Zhang C, Arterioscler Thromb Vasc Biol 2007 27 4 871 7 10.1161/01.ATV.0000259358.31234.37 17272755 (Pubitemid 46606719)
108. Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice. Cola MS, Gava AL, Meyrelles SS, Vasquez EC, Lipids Health Dis 2010 9 51 10.1186/1476-511X-9-51 20482882
109. Cerebral vascular dysfunction during hypercholesterolemia. Kitayama J, Faraci FM, Lentz SR, Heistad DD, Stroke 2007 38 7 2136 41 10.1161/STROKEAHA.107. 481879 17525390 (Pubitemid 47012280)
110. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Brandes RP, Schmitz-Winnenthal FH, Félétou M, Gödecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R, Proc Natl Acad Sci USA 2000 97 17 9747 52 10944233 (Pubitemid 30650847)
111. Hyperreactivity of coronary arterial smooth muscles in response to ergonovine from rabbits with hereditary hyperlipidemia. Yokoyama M, Akita H, Mizutani T, Fukuzaki H, Watanabe Y, Circ Res 1983 53 1 63 71 6861297 (Pubitemid 13031769)
112. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL, Circ Res 1984 54 6 711 8 6733866 (Pubitemid 14091676)
113. Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress. Hans CP, Feng Y, Naura AS, Zerfaoui M, Rezk BM, Xia H, Kaye AD, Matrougui K, Lazartigues E, Boulares AH, PLoS One 2009 4 10 7430 10.1371/journal.pone.0007430 19823587
114. BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Virág L, Szabá C, Free Radic Biol Med 2000 29 8 704 13 10.1016/S0891-5849(00)00359-2 11053771
115. Intrinsic resistance to apoptosis of colon epithelial cells is a potential determining factor in the susceptibility of the A/J mouse strain to dimethylhydrazine-induced colon tumorigenesis. Oumouna-Benachour K, Oumouna M, Zerfaoui M, Hans C, Fallon K, Boulares AH, Mol Carcinog 2007 46 12 993 1002 10.1002/mc.20351 17538954 (Pubitemid 350234256)
116. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM, Circulation 2002 106 8 927 32 10.1161/01.CIR.0000026393.47805.21 12186795 (Pubitemid 34925325)
117. Vascular cell senescence: contribution to atherosclerosis. Minamino T, Komuro I, Circ Res 2007 100 1 15 26 10.1161/01.RES.0000256837.40544.4a 17204661 (Pubitemid 46074968)
118. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y, J Atheroscler Thromb 2010 17 5 431 5 10.5551/jat.3525 20215708
119. Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS, Lipids Health Dis 2010 9 87 10.1186/1476-511X-9-87 20723257
120. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I, Circulation 2002 105 13 1541 4 10.1161/01.CIR.0000013836.85741.17 11927518 (Pubitemid 34297628)
121. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS, Circ Res 2001 89 9 793 8 10.1161/hh2101.098443 11679409 (Pubitemid 34633850)
122. The impact of progenitor cells in atherosclerosis. Xu Q, Nat Clin Pract Cardiovasc Med 2006 3 2 94 101 10.1038/ncpcardio0396 16446778 (Pubitemid 43203378)
123. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Wassmann S, Werner N, Czech T, Nickenig G, Circ Res 2006 99 8 74 83 10.1161/01.RES.0000246095.90247.d4 16990568 (Pubitemid 44556373)
124. Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Porto ML, Lima LC, Pereira TM, Nogueira BV, Tonini CL, Campagnaro BP, Meyrelles SS, Vasquez EC, Lipids Health Dis 2011 10 155 10.1186/1476-511X-10-155 21896159
125. Sildenafil increases endothelial progenitor cell function and improves ischemia-induced neovascularization in hypercholesterolemic apolipoprotein E-deficient mice. Dussault S, Maingrette F, Ménard C, Michaud S-E, Haddad P, Groleau J, Turgeon J. Perez G, Rivard A, Hypertension 2009 54 1043 49 10.1161/HYPERTENSIONAHA.109.139451 19770400